Breaking News, Promotions & Moves

Avalere Health Taps Amar Urhekar as CEO

Urhekar joined Avalere Health in 2023 as Chief Operations Officer.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Global strategic partner in healthcare, Avalere Health, has appointed Amar Urhekar as its new Chief Executive Officer (CEO).
 
Urhekar joined Avalere Health in 2023 as Chief Operations Officer (COO) to unify the organization and build a global interdisciplinary offering across the product lifecycle. Now, 18 months later, he will be responsible for the overall leadership of Avalere Health.
 
“Clients need partners who can navigate the complex confluence of stakeholders—from healthcare providers to payers, policymakers, and patients,” said Urhekar. “They need a strategic partner that can be at the center of their business and understand the evolving challenges. From driving decisions on investing in healthcare assets to policy influences and market access needs, medical communications and marketing brand launches, we have the exceptional talent with the wisdom and experience to guide, create, and implement successful solutions.”
 
Urhekar brings a wealth of experience successfully driving transformative initiatives, including mergers and acquisitions, reinventing local and global organizations across IPG, Ashfield Health, and most recently, Inizio Evoke. His global career spanning multiple countries, driving business growth, and building purpose-led high-performing teams, makes him suitable to lead Avalere Health in its next phase of evolution.
 
Urhekar replaces former CEO, Jon Koch, as part of a planned succession. Urhekar will continue to build on the strong foundation built by Koch over the last three and half years. Koch will be a strategic advisor to our Board until the end of March 2025.
 
“Avalere Health is ready to achieve its true potential,” said Urhekar. “I look forward to partnering with our teams to further create an inspiring company that will amplify the patient voice like never before.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters